Arcus Biosciences Inc
NYSE:RCUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arcus Biosciences Inc
NYSE:RCUS
|
US |
|
Mitsubishi Electric Corp
TSE:6503
|
JP |
|
East Japan Railway Co
TSE:9020
|
JP |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
US |
|
Travel + Leisure Co
NYSE:TNL
|
US |
|
Sabra Health Care REIT Inc
NASDAQ:SBRA
|
US |
|
T
|
Talkspace Inc
NASDAQ:TALK
|
US |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
JP |
|
Riber SA
PAR:ALRIB
|
FR |
|
Teck Resources Ltd
NYSE:TECK
|
CA |
|
T
|
Teekay Tankers Ltd
NYSE:TNK
|
CA |
|
Deutsche Post AG
XETRA:DPW
|
DE |
|
H
|
Heriot REIT Ltd
JSE:HET
|
ZA |
|
Campbell Soup Co
NYSE:CPB
|
US |
|
Berkeley Group Holdings PLC
LSE:BKG
|
UK |
|
EchoStar Corp
NASDAQ:SATS
|
US |
|
GE Vernova Inc
MIL:1GEV
|
US |
|
N
|
NextCell Pharma AB
STO:NXTCL
|
SE |
|
Everbright Securities Co Ltd
SSE:601788
|
CN |
|
MMG Ltd
HKEX:1208
|
AU |
|
Pebblebrook Hotel Trust
NYSE:PEB
|
US |
|
Farmer Bros Co
NASDAQ:FARM
|
US |
|
LIC Housing Finance Ltd
NSE:LICHSGFIN
|
IN |
|
Fuji Electric Co Ltd
TSE:6504
|
JP |
Bankruptcy Probability
Arcus Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Arcus Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Arcus Biosciences Inc
NYSE:RCUS
|
3.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
177.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Arcus Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Arcus Biosciences Inc has total debt of 99m USD. This includes both short-term (0 USD) and long-term (99m USD) debt.
You can find a full breakdown on its Balance Sheet.
